摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

d-biotinol | 526-67-0

中文名称
——
中文别名
——
英文名称
d-biotinol
英文别名
dl-Biotinol;4t-(5-hydroxy-pentyl)-(3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one;Tetrahydro-4-(5-hydroxypentyl)-1H-thieno[3,4-d]imidazol-2(3H)-one;4-(5-hydroxypentyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one
d-biotinol化学式
CAS
526-67-0
化学式
C10H18N2O2S
mdl
——
分子量
230.331
InChiKey
RGIKRHKHRAAZIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    500.0±35.0 °C(Predicted)
  • 密度:
    1.177±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    86.7
  • 氢给体数:
    3
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    d-biotinolbarium dihydroxide 作用下, 以 为溶剂, 反应 18.0h, 以87%的产率得到5-(3,4-Diamino-tetrahydro-thiophen-2-yl)-pentan-1-ol; compound with sulfuric acid
    参考文献:
    名称:
    Flaster, Harry; Kohn, Harold, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 1425 - 1436
    摘要:
    DOI:
  • 作为产物:
    描述:
    biotin 在 lithium aluminium tetrahydride 作用下, 以 吡啶乙醚 为溶剂, 以60%的产率得到d-biotinol
    参考文献:
    名称:
    Flaster, Harry; Kohn, Harold, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 1425 - 1436
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • AVOIDANCE OF NON-SPECIFIC BINDING ON AN ACOUSTIC WAVE BIOSENSOR USING LINKER AND DILUENT MOLECULES FOR DEVICE SURFACE MODIFICATION
    申请人:THOMPSON Michael
    公开号:US20110306771A1
    公开(公告)日:2011-12-15
    An acoustic wave biosensor comprising a surface of a mixed self-assembling monolayer for receiving a probe-biomolecule is described herein. The biosensor surface may comprise a piezoelectric quartz crystal,—for detection purposes with the electromagnetic piezoelectric acoustic sensor (EMPAS)—upon which a mixed self-assembling monolayer is formed, which includes at least one linker, such as 2,2,2-trifluoroethyl-13-trichlorosilyl-tridecanoate (TTTA); its oligoethylene glycol (OEG) analog OEGylated TTTA (OEG-TTTA); S-(2-(2-(2-(3-trichlorosilyl-propyloxy)-ethoxy)-ethoxy)-ethyl)-benzenethiosulfonate (OEG-TU BTS). Linker/diluent systems for attaching a functionalizing entity to the surface of a biosensor are described, as well as methods for preparing a biosensor surface with an oligoethylene glycol linker.
    这里描述了一种声波生物传感器,包括用于接收探针生物分子的混合自组装单分子层的表面。生物传感器表面可能包括压电石英晶体,用于检测目的与电磁压电声传感器(EMPAS)一起使用,其上形成了混合自组装单分子层,其中包括至少一种连接剂,如2,2,2-三氟乙基-13-三氯硅基-十三酸酯(TTTA);其寡乙二醇(OEG)类似物OEG化的TTTA(OEG-TTTA);S-(2-(2-(2-(3-三氯硅基-丙氧基)-乙氧基)-乙氧基)-乙基)-苯基硫酸酯(OEG-TU BTS)。描述了用于将功能化实体连接到生物传感器表面的连接剂/稀释剂系统,以及使用寡乙二醇连接剂制备生物传感器表面的方法。
  • SPECIFICALLY TARGETED CATALYTIC ANTAGONISTS AND USES THEREOF
    申请人:Davis Benjamin G.
    公开号:US20110262419A1
    公开(公告)日:2011-10-27
    This invention provides chimeric molecules that are catalytic antagonists of a target molecule. The catalytic antagonists of this invention preferably comprise a targeting moiety attached to an enzyme that degrades the molecule specifically bound by the targeting moiety. The catalytic antagonists of this invention thus bind to a target recognized by the targeting moiety (e.g., a receptor) the enzyme component of the chimera then degrades all or part of the target. This typically results in a reduction or loss of activity of the target and release of the chimeric molecule. The chimeric molecule is then free to attack and degrade another target molecule.
    本发明提供了嵌合分子,其是目标分子的催化拮抗剂。本发明的催化拮抗剂优选包含一个定向基团和一个酶,该酶特异性降解定向基团所结合的分子。本发明的催化拮抗剂因此结合到定向基团识别的目标上(例如受体),嵌合体的酶组分然后降解目标的全部或部分。这通常导致目标的活性降低或丧失,并释放嵌合分子。然后嵌合分子就可以自由攻击和降解另一个目标分子。
  • [EN] MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR<br/>[FR] DÉRIVÉ DE POLYÉTHYLÈNE GLYCOL MULTIFONCTIONNALISÉ ET SON PROCÉDÉ DE PRÉPARATION<br/>[ZH] 一种多官能化聚乙二醇衍生物及其制备方法
    申请人:XIAMEN SINOPEG BIOTECH CO LTD
    公开号:WO2016050210A1
    公开(公告)日:2016-04-07
    本发明公开一种多官能化聚乙二醇衍生物及其制备方法。其具有H型结构,如式(1)所示,其中包括一个线性主轴LPEG及四个PEG分支链,n1、n2、n3、n4分别为分支链的聚合度;U1、U2为连接主轴LPEG和两个PEG分支链的三价支化基团;F1、F2含有功能性基团或其被保护形式R01,且可不含或含有支化基团G,相应地,R01的个数为1个或多个;F1、F2相同或不同;分子中任一个连接基或其与相邻杂原子基团形成的连接基可稳定存在或可发生降解;分子中任一个PEG链段各自独立地为多分散性或单分散性。该官能化聚乙二醇在支化结构、分支臂的长度等方面灵活多样、各种参数和性能指标可调易控,应用广泛。
  • US8491958B2
    申请人:——
    公开号:US8491958B2
    公开(公告)日:2013-07-23
  • Flaster, Harry; Kohn, Harold, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 1425 - 1436
    作者:Flaster, Harry、Kohn, Harold
    DOI:——
    日期:——
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 (3aS,4S,6aR)-4-(5-(1-(2-hydroxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one (3aS,4S,6aR)-4-(5-(1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one methyl (4E,Z)-6-({5-[(3aS,4S,6aR)-1,3-bis(4-methoxybenzyl)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}oxy)hex-4-enoate 1H-thieno<3,4-d>imidazol-2(3H)-one, tetrahydro-4-(5-chloropentyl)-, <3aS-(3aα,4β,6aα)>- (3aS,4Z,6aR)-5-{hexahydro-2-oxo-4H-thieno[3,4-d]imidazol-4-ylidene}pentanoic acid methyl ester (3aS,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno[3,4-d]-imidazole-2(3H)-one-4-yl-pentanoic acid (3aS,4S,6aR)-4-(5-(1-(4-iodobenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 1-amino-17-N-(biotinylamido)-3,6,9,12,15-pentaoxaheptadecane (3aS,4S,6aR)-4-(4-isocyanatobutyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 2-[1-Hydroxy-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentylidene]-5,5-dimethyl-cyclohexane-1,3-dione (3aS,4S,6aR)-4-(4-aminobut-1-yl)hexahydro-1H-thieno[3,4-d]imidazolidin-2-one hydrochloride Methyl-bisnorbiotinyl-keton 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-hydroxy-thiophen 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoic acid tert-butyl 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoate 1-{5-[(2,5-dioxopyrrolidin-1-yl)oxy]-5-oxopentyl}-3-{4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}urea Trimetaphan camsylate (3aS,4S,6aR)-4-hexyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 1-Benzyl-1,3a,4,6,7,8,8a,8b-octahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium-2-olate--hydrogen chloride (1/1) (3aα,6aα)-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazole (3aα,6aβ)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (E)-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pent-2-enoic acid (3aS,4Z,6aR)-1,3-dibenzyl-4-(3-methoxypropylidene)-6,6a-dihydro-3aH-thieno[3,4-d]imidazol-2-one (3aS,6aR)-1-Isopropyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one (3AS-cis)-1,3-dibenzyltetrahydro-4-(3-methoxypropylidene)-1H-thieno(3,4-d)imidazol-2(3H)-one (3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 2-oxo-(3ar,3bξ,8ac)-decahydro-thieno[1',2':1,2]thieno[3,4-b]imidazolium; bromide biotin hydrazide (3aS,4S,6aR)-1,3-bis[(3-bromophenyl)methyl]-4-(5-hydroxypentyl)-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one 4-Pentyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-3-benzyl-4-pentyl-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-hept-6-ynyl-2-oxo-tetrahydro-thieno[3,4-d]imidazole-1,3-dicarboxylic acid di-tert-butyl ester (3aS,4S,6aR)-4-(6-hydroxyhexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-oct-7-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoic acid 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentyl dimethyl phosphite Methyl-tetranorbiotinyl-keton (2aR,7aS,7bS)-Hexahydro-2H-1-thia-3,4a-diazacyclopent[cd]inden-4(3H)-one 8-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)octanoic acid 2'-thiobiotinol